Engineering the insulin signal peptide to protect human pancreatic beta cells from autoimmune destruction.
Beta cells expressing insulin with chromogranin-A signal peptide evaded recognition and killing by autoreactive T cells without inducing ER stress or compromising cellular identity, and may offer a targeted alternative to systemic immunosuppression to be used in stem-cell-derived therapies by engineering endogenous ins...